Matthew B. Klein, Chief Operating Officer at PTC THERAPEUTICS, INC. (PTCT), sold 775 shares at $38.53 ($30K) on 2022-01-07, disclosed to the SEC on 2022-01-11.
Open-market sale of $30k PTCT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |